RaySearch Laboratories is highlighting that the U.K.'s Royal Marsden NHS Foundation Trust will be the first facility in the world to implement online adaptive radiation therapy (OART) with the company's RayStation and RayCare systems.
The most recent acquisition also includes the new ARTemis OART solution under development in combination with the Radixact Treatment Delivery System from Accuray.
The Royal Marsden has been using RayStation for conventional treatment planning since 2016. Recent funding from The Royal Marsden Cancer Charity has allowed the center to acquire two additional Radixact treatment delivery machines from Accuray with the intention of using these machines for OART.
ARTemis is a collaborative effort between RaySearch and Accuray to provide an online adaptive solution for clinicians using the RayStation treatment planning system with the Radixact Treatment Delivery System. It will leverage RayStation’s automated adaptive replanning, RayCare’s clinical workflow management tools, and the Accuray ClearRTTM imaging, to make way for online adaptive therapy.